Alzheimer's disease

News

The PrevenTRON trial of Roche's Brainshuttle drug trontinemab in preclinical Alzheimer's disease has gotten underway in the UK.

News

Roche has won US FDA clearance for a blood test that could move Alzheimer’s biomarker testing further into primary care.

News

The FDA approves Lantheus' Tauklarify radiodiagnostic PET to evaluate NFT pathology in Alzheimer's disease.

News

Researchers have found that people with early Alzheimer's are not following guidelines for promoting brain health, even if they are on drug therapy.

News

Biogen/Eisai's Alzheimer's drug Leqembi continued to grow in Q2, driven by a new subcutaneous version, but fell a little short of expectations.

News

Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, to a mixed response.